Skip to main content

Table 2 Subgroup analyses based on the data of TLR and stent thrombosis; CI - confidence interval, DAPT - dual antiplatelet therapy, RR - risk ratio, TLR - target lesion revascularization

From: A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients

 

Stent thrombosis

TLR

Subgroups

No. of studies

RR (95% CI)

Interaction P value

No. of studies

RR (95% CI)

Interaction P value

≤30% patients with insulin therapy

2

0.34 (0.03, 3.43)

0.91

2

0.92 (0.12, 7.32)

0.74

>  30% patients with insulin therapy

5

0.39 (0.22, 0.70)

4

0.65 (0.46, 0.91)

DAPT duration = 6 months

2

0.32 (0.09, 1.05)

0.69

2

1.09 (0.67, 1.76)

0.01

DAPT duration = 12 months

6

0.42 (0.23, 0.75)

5

0.50 (0.34, 0.74)

<  24-months follow-up

4

0.61 (0.28, 1.30)

0.12

4

0.72 (0.32, 1.58)

0.9

≥24-months follow-up

4

0.26 (0.13, 0.55)

3

0.68 (0.46, 1.00)